Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond annotations (readOnlyHint, openWorldHint, idempotentHint), the description adds specific behaviors: pulls latest 10-K financials with correct fiscal year handling, FAERS drug data, sorted results, citation URIs, and performance benefit replacing 8-15 lookups.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Concise multi-sentence description with front-loaded purpose and triggers; every sentence adds value without redundancy.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given tool complexity (two types, diverse data sources, fiscal year handling, sorted results, citations), the description covers all essential aspects for correct invocation and expectations.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schemas cover parameters fully, but description enriches them: explains what data each type pulls (company: financials, drug: adverse events/trials), gives example values (tickers, names), and notes sorting by primary metric.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool performs side-by-side comparison of 2-5 companies or drugs in a single parallel call, listing specific trigger phrases and distinguishing it from sequential single-entity lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly instructs 'ALWAYS PREFER over sequential single-pack lookups when comparing entities', providing clear when-to-use guidance and examples of comparison queries.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Several tools have heavily overlapping purposes, notably ask_pipeworx vs ask_pipeworx_beta vs ask_pipeworx_grounded, and the cluster of polymarket tools covers adjacent prediction-market analysis territory. The PomBase-specific tools are distinct, but the overall set creates real selection ambiguity.

Naming Consistency3/5

Most names follow a readable snake_case style and many use verb-first patterns, but there is notable mixing: ask_pipeworx is a brand-style exception, entity_profile and polymarket_arbitrage are noun-first, and remember/recall/forget form an inconsistent trio. Not chaotic, but not a clean predictable convention.

Tool Count2/5

33 tools is excessive for a server named Pombase, where only get_gene and get_reference actually serve that domain. Even as a broad data-research server, the count is above the 25-tool threshold and includes many auxiliary utilities that feel bolted on rather than part of a focused surface.

Completeness2/5

The PomBase-specific coverage is severely thin: only systematic-ID gene lookup and PubMed-ID reference lookup, with no gene-name search, annotations browsing, phenotype data, or sequence access. The broader Pipeworx surface is extensive, but for the apparent Pombase purpose, agents will frequently hit dead ends.